20 Most Shorted Stocks — Short Interest Report May 30, 2026

Overview of Short Interest Short interest data as of May 30, 2026, highlights a significant bearish sentiment across various stocks, with some exhibiting high potential for short squeezes. Below is a detailed analysis of the 20 most shorted stocks currently in the market.

1. Groupon Inc (GRPN) - **Short Interest**: 62.16% - **Days to Cover**: 10 - **Bearish Thesis**: Groupon continues to struggle with declining revenues and increased competition in the discount retail space, leading to skepticism about its business model. - **Squeeze Catalysts**: Upcoming earnings report on June 15, 2026. - **Media Activity**: Increased negative coverage regarding its customer acquisition costs. - **Important Dates**: Earnings on June 15, 2026. - **Squeeze Risk Score**: 8

2. Hertz Global Holdings Inc (HTZ) - **Short Interest**: 43.73% - **Days to Cover**: 6 - **Bearish Thesis**: The car rental market remains volatile post-pandemic, with rising interest rates impacting fleet financing. - **Squeeze Catalysts**: Potential merger news could emerge as the company explores partnerships. - **Media Activity**: Analysts have expressed concern over debt levels, contributing to negative sentiment. - **Important Dates**: None reported. - **Squeeze Risk Score**: 7

3. Critical Metals Corp. (CRML) - **Short Interest**: 41.98% - **Days to Cover**: 5 - **Bearish Thesis**: Investors are skeptical about the long-term viability of its mining projects, particularly amid fluctuating commodity prices. - **Squeeze Catalysts**: Upcoming project updates expected in Q3 2026. - **Media Activity**: Limited media coverage but critical tweets from industry influencers highlighting risks. - **Important Dates**: Project update in August 2026. - **Squeeze Risk Score**: 6

4. 1-800-FLOWERS.COM, Inc. (FLWS) - **Short Interest**: 40.21% - **Days to Cover**: 4 - **Bearish Thesis**: Concerns over consumer spending patterns in the specialty retail sector are driving bearish sentiment. - **Squeeze Catalysts**: Seasonal sales data expected in mid-June. - **Media Activity**: Some positive reviews from influencers on social media. - **Important Dates**: Sales data update on June 10, 2026. - **Squeeze Risk Score**: 7

5. ARS Pharmaceuticals Inc (SPRY) - **Short Interest**: 38.06% - **Days to Cover**: 8 - **Bearish Thesis**: Regulatory hurdles are raising concerns about the approval of its lead product, impacting stock performance. - **Squeeze Catalysts**: FDA decision on drug application expected by July 2026. - **Media Activity**: Mixed coverage with some analysts bullish on potential FDA approval. - **Important Dates**: FDA decision date in July 2026. - **Squeeze Risk Score**: 9

6. LifeVantage Corporation (LFVN) - **Short Interest**: 37.64% - **Days to Cover**: 3 - **Bearish Thesis**: The company faces skepticism regarding its multi-level marketing structure and declining sales. - **Squeeze Catalysts**: New product launch expected in Q4 2026. - **Media Activity**: Influencers discussing the viability of its business model. - **Important Dates**: Product launch in November 2026. - **Squeeze Risk Score**: 5

7. SoundHound AI Inc (SOUN) - **Short Interest**: 37.26% - **Days to Cover**: 4 - **Bearish Thesis**: Analysts question the sustainability of its technology amid competition from established players. - **Squeeze Catalysts**: Upcoming tech conference where new products may be showcased. - **Media Activity**: Increasing attention from tech blogs, some with a positive outlook. - **Important Dates**: Tech conference in July 2026. - **Squeeze Risk Score**: 6

8. C3.ai Inc (AI) - **Short Interest**: 37.12% - **Days to Cover**: 5 - **Bearish Thesis**: High valuation relative to growth prospects leads to skepticism among investors. - **Squeeze Catalysts**: Earnings report scheduled for June 22, 2026. - **Media Activity**: Analysts remain divided, with some bullish calls. - **Important Dates**: Earnings on June 22, 2026. - **Squeeze Risk Score**: 7

9. Purecycle Technologies Inc (PCT) - **Short Interest**: 36.89% - **Days to Cover**: 6 - **Bearish Thesis**: Concerns regarding the scalability of its recycling technology. - **Squeeze Catalysts**: Partnerships expected to be announced in Q3 2026. - **Media Activity**: Increasing coverage on sustainability initiatives. - **Important Dates**: Partnership announcements in September 2026. - **Squeeze Risk Score**: 6

10. New Fortress Energy Inc. (NFE) - **Short Interest**: 35.63% - **Days to Cover**: 5 - **Bearish Thesis**: The volatility in energy prices raises doubts about profitability. - **Squeeze Catalysts**: Expected earnings report in early June 2026. - **Media Activity**: Analysts are cautious about energy sector exposure. - **Important Dates**: Earnings on June 5, 2026. - **Squeeze Risk Score**: 7

11. The Children's Place, Inc. (PLCE) - **Short Interest**: 34.95% - **Days to Cover**: 3 - **Bearish Thesis**: Declining sales amid a challenging retail environment. - **Squeeze Catalysts**: Seasonal sales report due in June 2026. - **Media Activity**: Limited coverage, mostly negative. - **Important Dates**: Sales report on June 15, 2026. - **Squeeze Risk Score**: 5

12. iPower Inc. (IPW) - **Short Interest**: 34.78% - **Days to Cover**: 2 - **Bearish Thesis**: Concerns over the sustainability of its revenue model. - **Squeeze Catalysts**: Potential acquisition rumors. - **Media Activity**: Minimal, but some positive influencer mentions. - **Important Dates**: None reported. - **Squeeze Risk Score**: 4

13. TTEC Holdings, Inc. (TTEC) - **Short Interest**: 34.60% - **Days to Cover**: 4 - **Bearish Thesis**: High competition in customer experience solutions. - **Squeeze Catalysts**: New contract announcements expected in Q3 2026. - **Media Activity**: Analysts have mixed reviews. - **Important Dates**: Contract news anticipated in August 2026. - **Squeeze Risk Score**: 5

14. Evgo Inc (EVGO) - **Short Interest**: 34.51% - **Days to Cover**: 5 - **Bearish Thesis**: Market saturation in EV charging infrastructure raises concerns. - **Squeeze Catalysts**: Partnership announcements with automakers expected soon. - **Media Activity**: Increased visibility in EV discussions. - **Important Dates**: None reported. - **Squeeze Risk Score**: 6

15. Recursion Pharmaceuticals, Inc. (RXRX) - **Short Interest**: 34.22% - **Days to Cover**: 3 - **Bearish Thesis**: Competitive pressures in biotech are leading to skepticism about its pipeline. - **Squeeze Catalysts**: Upcoming clinical trial results expected in July 2026. - **Media Activity**: Positive sentiment from biotech analysts. - **Important Dates**: Clinical results in July 2026. - **Squeeze Risk Score**: 7

16. Hims & Hers Health, Inc. (HIMS) - **Short Interest**: 33.25% - **Days to Cover**: 4 - **Bearish Thesis**: Regulatory scrutiny over telehealth services raises concerns. - **Squeeze Catalysts**: Expected earnings report on June 20, 2026. - **Media Activity**: Positive influencer engagement. - **Important Dates**: Earnings on June 20, 2026. - **Squeeze Risk Score**: 6

17. Serve Robotics Inc. (SERV) - **Short Interest**: 32.01% - **Days to Cover**: 3 - **Bearish Thesis**: High operational costs and competition in the robotics sector. - **Squeeze Catalysts**: New product launches in Q3 2026. - **Media Activity**: Moderate coverage, with some interest from tech influencers. - **Important Dates**: Product launch in August 2026. - **Squeeze Risk Score**: 5

18. Sphere Entertainment Co. (SPHR) - **Short Interest**: 31.94% - **Days to Cover**: 4 - **Bearish Thesis**: Declining attendance in entertainment venues raises concerns. - **Squeeze Catalysts**: New lineup announcements for summer events. - **Media Activity**: Some positive mentions in entertainment news. - **Important Dates**: Event announcements in June 2026. - **Squeeze Risk Score**: 4

19. Eos Energy Enterprises Inc (EOSE) - **Short Interest**: 30.71% - **Days to Cover**: 3 - **Bearish Thesis**: The energy storage sector is facing increased competition. - **Squeeze Catalysts**: New partnerships expected in Q2 2026. - **Media Activity**: Limited but slightly positive coverage. - **Important Dates**: Partnership announcements in July 2026. - **Squeeze Risk Score**: 5

Summary ### Top 3 Most Dangerous Shorts 1. **ARS Pharmaceuticals Inc (SPRY)** - Regulatory hurdles could lead to a significant squeeze if FDA approval is granted. 2. **Groupon Inc (GRPN)** - Upcoming earnings could trigger a reversal in sentiment. 3. **C3.ai Inc (AI)** - High valuation and upcoming earnings create a precarious situation for shorts.

### Short of the Week - ARS Pharmaceuticals Inc (SPRY) - With a high short interest percentage and a critical FDA date approaching, this stock stands out as the most at risk of a squeeze.

### Pattern Analysis The short interest data reflects a sector-wide pattern, particularly in retail and biotechnology, where companies face significant headwinds from market conditions and regulatory scrutiny. Stocks like Groupon and ARS Pharmaceuticals exemplify the risks and potential rewards inherent in the current short-selling climate.

Educational content only. Not financial advice. DYOR.